These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28057172)

  • 1. Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8.
    Niwa T; Imagawa Y
    J Pharm Pharm Sci; 2016; 19(4):423-429. PubMed ID: 28057172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Genetic Polymorphism on the Inhibition of Azole Antifungal Agents Against CYP2C9-Mediated Metabolism.
    Niwa T; Hata T
    J Pharm Sci; 2016 Mar; 105(3):1345-8. PubMed ID: 26886310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.
    Niwa T; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Sep; 28(9):1805-8. PubMed ID: 16141567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of a cDNA encoding a novel marmoset CYP2C enzyme, expression in yeast cells and characterization of its enzymatic functions.
    Narimatsu S; Torigoe F; Tsuneto Y; Saito K; Hanioka N; Masuda K; Katsu T; Yamamoto S; Yamano S; Baba T; Miyata A
    Biochem Pharmacol; 2006 Dec; 72(12):1738-48. PubMed ID: 17010942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450.
    Niwa T; Morimoto M; Hirai T; Hata T; Hayashi M; Imagawa Y
    J Toxicol Sci; 2016 Feb; 41(1):143-6. PubMed ID: 26763401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of drug-metabolizing enzyme activity in human hepatic cytochrome P450s by bisphenol A.
    Niwa T; Tsutsui M; Kishimoto K; Yabusaki Y; Ishibashi F; Katagiri M
    Biol Pharm Bull; 2000 Apr; 23(4):498-501. PubMed ID: 10784435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine.
    Niwa T; Sato R; Yabusaki Y; Ishibashi F; Katagiri M
    Xenobiotica; 1999 Feb; 29(2):187-93. PubMed ID: 10199594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition.
    Niwa T; Yamazaki H
    Curr Drug Metab; 2012 Oct; 13(8):1145-59. PubMed ID: 22571484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-drug interaction of antifungal drugs].
    Niwa T; Shiraga T; Takagi A
    Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450.
    Niwa T; Imagawa Y; Yamazaki H
    Curr Drug Metab; 2014; 15(7):651-79. PubMed ID: 25429674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
    Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y
    Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human hepatic cytochrome P450s and steroidogenic CYP17 by nonylphenol.
    Niwa T; Maekawa Y; Fujimoto M; Kishimoto K; Yabusaki Y; Ishibashi F; Katagiri M
    Biol Pharm Bull; 2002 Feb; 25(2):235-8. PubMed ID: 11853173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes.
    Custodio JM; Donaldson KM; Hunt HJ
    J Clin Pharmacol; 2021 Feb; 61(2):244-253. PubMed ID: 32869328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs.
    Sakaeda T; Iwaki K; Kakumoto M; Nishikawa M; Niwa T; Jin JS; Nakamura T; Nishiguchi K; Okamura N; Okumura K
    J Pharm Pharmacol; 2005 Jun; 57(6):759-64. PubMed ID: 15969931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activities.
    Satoh T; Fujisawa H; Nakamura A; Takahashi N; Watanabe K
    J Pharm Pharm Sci; 2016; 19(2):188-97. PubMed ID: 27518169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes.
    Kuroha M; Kuze Y; Shimoda M; Kokue E
    Am J Vet Res; 2002 Jun; 63(6):900-5. PubMed ID: 12061540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
    Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
    Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.